These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8993755)

  • 1. Inhibition of in vitro HIV infection by dialysable leucocyte extracts.
    Fernandez-Ortega C; Dubed M; Ruibal O; Vilarrubia OL; Menéndez de San Pedro JC; Navea L; Ojeda M; Araña MJ
    Biotherapy; 1996; 9(1-3):33-40. PubMed ID: 8993755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dialysable leucocyte extract (DLE) reduces lipopolysaccharide-induced tumour necrosis factor secretion in human leucocytes.
    Ojeda Ojeda M; Fernandez Ortega CB; Araña Rosaínz MJ
    Biotherapy; 1996; 9(1-3):163-70. PubMed ID: 8993776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of DLE fractions on GM-progenitors of haematopoietic stem cells in vitro.
    Barnet K; Vacek A; Cech K; Pekárek J
    Biotherapy; 1996; 9(1-3):171-4. PubMed ID: 8993777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of the effect of temporary removal of HIV drug pressure.
    Witvrouw M; Pannecouque C; Desmyter J; De Clercq E; Andries K
    Antiviral Res; 2000 Jun; 46(3):215-21. PubMed ID: 10867159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of target cell availability on HIV-1 production in vitro.
    Schwartz EJ; Neumann AU; Teixeira AV; Bruggeman LA; Rappaport J; Perelson AS; Klotman PE
    AIDS; 2002 Feb; 16(3):341-5. PubMed ID: 11834944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of serotonin and melanin on in vitro HIV-1 infection.
    Sidibe S; Saal F; Rhodes-Feuillette A; Lagaye S; Pelicano L; Canivet M; Peries J; Dianoux L
    J Biol Regul Homeost Agents; 1996; 10(1):19-24. PubMed ID: 9049777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on anti-HIV-1 activities of composite extract from salvia yunnanensis].
    Peng ZG; Qin DH; Teng L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Aug; 28(8):711-5. PubMed ID: 18928096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fullerene Derivatives Strongly Inhibit HIV-1 Replication by Affecting Virus Maturation without Impairing Protease Activity.
    Martinez ZS; Castro E; Seong CS; Cerón MR; Echegoyen L; Llano M
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5731-41. PubMed ID: 27431232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New bis(thiosemicarbazonate) gold(III) complexes inhibit HIV replication at cytostatic concentrations: potential for incorporation into virostatic cocktails.
    Fonteh PN; Keter FK; Meyer D
    J Inorg Biochem; 2011 Sep; 105(9):1173-80. PubMed ID: 21708102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyproline-containing collagen peptide derived from the skin of the Alaska pollack inhibits HIV-1 infection.
    Jang IS; Park SJ
    Mol Med Rep; 2016 Dec; 14(6):5489-5494. PubMed ID: 27878297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-induced leukocyte extract reduces HIV replication and TNF secretion.
    Fernández-Ortega C; Dubed M; Ramos Y; Navea L; Alvarez G; Lobaina L; López L; Casillas D; Rodríguez L
    Biochem Biophys Res Commun; 2004 Dec; 325(3):1075-81. PubMed ID: 15541398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tyrosine kinase inhibitor Dasatinib blocks in-vitro HIV-1 production by primary CD4+ T cells from HIV-1 infected patients.
    Pogliaghi M; Papagno L; Lambert S; Calin R; Calvez V; Katlama C; Autran B
    AIDS; 2014 Jan; 28(2):278-81. PubMed ID: 24361684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV type 1 replication in CD4+ and CD14+ cells purified from HIV type 1-infected individuals by the 2-5A agonist immunomodulator, 2-5A(N6B).
    Dimitrova DI; Reichenbach NL; Yang X; Pfleiderer W; Charubala R; Gaughan JP; Suh B; Henderson EE; Suhadolnik RJ; Rogers TJ
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):123-34. PubMed ID: 17263642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the antiviral capacity of primary natural killer cells by optimized in vitro quantification of HIV-1 replication.
    He X; Simoneau CR; Granoff ME; Lunemann S; Dugast AS; Shao Y; Altfeld M; Körner C
    J Immunol Methods; 2016 Jul; 434():53-60. PubMed ID: 27094484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-incubation of cell-free HIV-1 group M isolates with non-nucleoside reverse transcriptase inhibitors blocks subsequent viral replication in co-cultures of dendritic cells and T cells.
    Njai HF; Lewi PJ; Janssen CG; Garcia S; Fransen K; Kestens L; Vanham G; Janssen PA
    Antivir Ther; 2005; 10(2):255-62. PubMed ID: 15865220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells.
    Bermejo M; López-Huertas MR; García-Pérez J; Climent N; Descours B; Ambrosioni J; Mateos E; Rodríguez-Mora S; Rus-Bercial L; Benkirane M; Miró JM; Plana M; Alcamí J; Coiras M
    Biochem Pharmacol; 2016 Apr; 106():30-45. PubMed ID: 26851491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of protein kinase C theta inhibitors for the control of HIV-1 replication in human CD4+ T cells reveals an effect on retrotranscription in addition to viral transcription.
    Bermejo M; López-Huertas MR; Hedgpeth J; Mateos E; Rodríguez-Mora S; Maleno MJ; Plana M; Swindle J; Alcamí J; Coiras M
    Biochem Pharmacol; 2015 Apr; 94(4):241-56. PubMed ID: 25732195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.
    Casoli C; Pilotti E; Perno CF; Balestra E; Polverini E; Cassone A; Conti S; Magliani W; Polonelli L
    AIDS; 2006 Apr; 20(7):975-80. PubMed ID: 16603848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiviral compound BIT225 inhibits HIV-1 replication in myeloid dendritic cells.
    Khoury G; Ewart G; Luscombe C; Miller M; Wilkinson J
    AIDS Res Ther; 2016; 13():7. PubMed ID: 26858771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies.
    Aquaro S; Svicher V; Schols D; Pollicita M; Antinori A; Balzarini J; Perno CF
    J Leukoc Biol; 2006 Nov; 80(5):1103-10. PubMed ID: 16931601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.